HomeHEMO • LON
add
Hemogenyx Pharmaceuticals PLC
Previous close
GBX 559.00
Day range
GBX 548.00 - GBX 639.85
Year range
GBX 124.00 - GBX 1,800.00
Market cap
36.10M GBP
Avg Volume
56.65K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.32M | -5.87% |
Net income | -2.50M | -77.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.27M | 6.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 226.73K | -86.20% |
Total assets | 3.10M | -49.29% |
Total liabilities | 3.65M | 17.94% |
Total equity | -546.41K | — |
Shares outstanding | 4.59M | — |
Price to book | -50.82 | — |
Return on assets | -106.59% | — |
Return on capital | -199.51% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.50M | -77.91% |
Cash from operations | -1.89M | -60.93% |
Cash from investing | 130.02K | 1,400.74% |
Cash from financing | 836.03K | -41.18% |
Net change in cash | 33.73K | -82.93% |
Free cash flow | -575.00K | 24.49% |
About
Founded
2013
Website
Employees
16
